HAE vs SRPT · P/E 35, rev $1.33B vs rev $1.13B
Haemonetics Corporation (HAE) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Haemonetics Corporation (HAE) is a medical devices company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported HAE revenue for 2026-03-28 was $1.33B. Net income was $97.3M. Revenue was down 2.0% from 2025-03-29 to 2026-03-28. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
HAE currently screens at market cap $3.24B and trailing P/E 34.8. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the HAE and SRPT stock pages for the full models.
Not investment advice.